STOP CANCER

Thank you for supporting us for 30 years! STOP CANCER’s legacy will live on with your future gifts to City of Hope https://ourhope.cityofhope.org/stopcancer, UCLA www.cancer.ucla.edu/stopcancer, and Keck Medicine of USC (USC Norris Comprehensive Cancer Center) http://uscnorriscancer.usc.edu/stopcancer

Photo Credit: Rick Wilkinson and Kanchan Gunjotikar

Happy New Year from all of us at STOP CANCER!

Remember the last time you used your phone and it left a nice warm spot on your face? - Is that causing cancer? Michael Aranda tells you all about the radiation on your cell phone.

Do Cell Phones Cause Cancer? Remember the last time you used your phone and it left a nice warm spot on your face? - Is that causing cancer? Michael Aranda tells you all about the radiat...

After her second diagnosis with cancer, Lila Javan had to put her dream of climbing Mt. Kilimanjaro on hold. But that didn't stop her from eventually reaching the peak, and this time she was able to bring along a special group of friends. Check it out!

Lila and the Mountain After her second diagnosis with cancer, Lila Javan had to put her dream of climbing Mt. Kilimanjaro on hold. But that didn't stop her from eventually reachin...

! Dr. Cobos is a physician-scientist and Assistant Professor in the Department of Pathology and Laboratory Medicine, Division of Neuropathology, at David Geffen School of Medicine at UCLA and the Ronald Reagan Medical Center. Dr. Cobos studies the basic mechanisms underlying the generation and maintenance of cell diversity in the central nervous system. She is using cell type-specific cellular, molecular and genetic techniques to understand how different populations of neurons and glia contribute to disease pathogenesis in the context of neurodegenerative disorders and brain cancer. The 2016 STOP CANCER Research Career Development Award has helped Dr. Cobos to conduct her research! Thank you, Dr. Cobos, for contributions to the fight to

Lewis Mitchell Neff's portraits capture struggle and triumph through a glimpse into a young woman's cancer diary.

This Evergreen Woman’s Cancer Diary Will Change The Way You View Portraits The portrait is one of art's most popular forms. This Denver artist is pushing its limits with an intimate exhibition.

Why don't we hear about people getting heart cancer? Turns out that some types of cells are less susceptible to cancer than others.

Why Is Heart Cancer So Rare? Why don't we hear about people getting heart cancer? Turns out that some types of cells are less susceptible to cancer than others. Hosted by: Michael Aranda...

Wishing you and yours a joyous holiday season!

! Meet Dr. Karim Chamie (2014 Research Career Development Award) and learn about the importance of broadening cancer surveillance. Dr. Chamie is an Assistant Professor in the Department of Urology at David Geffen School of Medicine at UCLA and is a Member of the JCCC Patients and Survivors Program Area. He is a practicing urologist at Ronald Reagan UCLA and Santa Monica Medical Centers. Dr. Chamie is studying the barriers that patients with bladder cancer encounter and hopes to integrate innovative ways to obviate some of the barriers to quality care. Recently honored with a STOP CANCER Research Career Development Award, Dr. Chamie is dedicated to changing the way cancer is treated at UCLA and worldwide! Thank you for your dedication to stopping cancer!

UCLA Study Reveals Importance of Broadening Cancer Surveillance - Karim Chamie, MD Nearly 1 in 12 patients with a common cancer develop a second unrelated cancer, a new UCLA study finds. More than half of second cancers prove fatal; researc...

"Difficulties are meant to rouse, not discourage. The human spirit is to grow strong by conflict." -William Ellery Channing

Cadmium may raise the risk of uterine cancer. Read about findings by researchers at University of Missouri

Cadmium may raise risk of endometrial cancer A case-control study of 1,510 women found that the risk of endometrial cancer was 22 percent higher in those with higher levels of cadmium.

! Dr. Berman (2014 STOP CANCER Research Career Development Award) is an Assistant Professor in Bioinformatics and Preventive Medicine at the Keck Medicine of USC (USC Norris Comprehensive Cancer Center) and the USC Epigenome Center. Dr. Berman develops whole-genome sequencing techniques to understand chromatin structure in primary human tissues, and is currently applying these methods to a set of tumor and matched colon tissues from 25 colon cancer patients. Thank you so much, Dr. Berman, for your efforts in the fight to

Keck Medicine of USC is the first academic medical center to offer prostate cancer treatment using robotic and focal high-intensity focused ultrasound (HIFU) – a nonsurgical and noninvasive alternative to surgery.

The Keck Effect: More Solutions for Prostate Cancer Keck Medicine of USC is the first academic medical center to offer prostate cancer treatment using robotic and focal high-intensity focused ultrasound (HIFU)...

"If you change the way you look at things, the things you look at change." -Wayne Dyer

is almost over, but it's not too late to donate! Celebrate generosity and give back now!

Help spread the word! STOP CANCER is participating in , the global initiative that celebrates generosity and kindness. Give back, donate now!

has arrived! Join the millions around the world and celebrate generosity and giving – support cancer research and let’s put an end to this insidious disease. Donate now!

"In order to succeed, we must first believe that we can." -Nikos Kazantzakis

Support us when you shop on Cyber Monday. Go to smile.amazon.com/ch/95-4167790 and Amazon donates to STOP CANCER.

! Dr. Andrew Goldstein is an Assistant Professor in the Departments of Molecular, Cell & Developmental Biology and Urology at the David Geffen School of Medicine at UCLA where his laboratory studies the cellular and molecular basis of prostate cancer. Dr. Goldstein’s research is focused on the intersection between cancer biology, stem cell biology and metabolism with the goal of identifying cellular and molecular mechanisms promoting prostate cancer initiation, progression, and treatment-resistance. Here he is receiving the 2017 STOP CANCER Research Career Development Award! Thank you for your dedicated research!

Andrew Goldstein, Ph.D. - 2017 STOP CANCER Research Career Development Award Dr. Goldstein’s research is focused on the intersection between cancer biology, stem cell biology and metabolism with the goal of identifying cellular and mo...

from all of us at !

"Cancer changes us, there's no doubt about that. But it's up to us to decide what that change will mean in our lives, and who we will become as a result." -Britta Aragon

Robin Roberts's story of surviving triple negative Breast Cancer

Triple Negative Breast Cancer Survivor: Robin Roberts Robin Roberts shares her triple negative breast cancer story of survival.

! Meet Dr. Hurvitz! She is Assistant Professor of Hematology/Oncology at and a researcher at JCCC. Dr. Hurvitz is conducting clinical trials in breast cancer treatment. In 2007, she designed and developed the TRIO B07 study to better understand why some HER2+ breast cancers do not respond to HER2-targeted therapy and to try to understand if there are biological markers (such as proteins) that could be identified to select patients who are most likely to respond to this therapy. Dr. Hurvitz's long-term goal is to increase the measurable cure rate for Stage IV breast cancer from 2-3 to more than 10 percent. Thank you, Dr. Hurvitz, for your efforts in the fight against cancer!

Dr. Sara Hurvitz Discusses the Latest Developments in Breast Cancer Research Dr. Sara Hurvitz works on finding treatment for an aggressive form of breast cancer called Triple Negative.

"You beat cancer by how you live, why you live and the manner in which you live." -Stuart Scott

Learn about the importance of Liquid Biopsy from City of Hope!

Precision Medicine and Liquid Biopsy: The Future of Diagnosing and Managing Disease Dr. Jeffrey Trent and Dr. Muhammad Murtaza of TGen, an affiliate of City of Hope, discuss the significance of liquid biopsies in the diagnoses and management...

A Laguna Beach mother read about a study at involving a unique immunotherapy called CAR-T cell therapy. She became the first patient to be involved in the clinical trial. Check out her story!

First-of-its-kind cancer lymphoma treatment help saves lives In 2015, Denise Delatorre was diagnosed with aggressive lymphoma. Chemotherapy failed to work. She was given six months to live. But the Laguna Beach mother ...